Open Nav

Please submit your session questions in advance at http://bit.ly/BIOCEO19question

Stephen From

CEO and President

EyeGate Pharmaceuticals, Inc.

Stephen has served as EyeGate's President, Chief Executive Officer, and director since October 2005. Prior to joining EyeGate, he was the Chief Financial Officer at Centelion SAS, an independent biotechnology subsidiary of Sanofi-Aventis. Previously, Mr. From spent several years as an investment banker specializing in the biotechnology and medical device sectors as Director in the Global Healthcare Corporate and Investment Banking Group and Head of European Life Sciences for Bank of America Securities. Mr. From holds a BSc from the University of Western Ontario, an accounting diploma from Wilfred Laurier University and has qualified as a Chartered Accountant in Ontario, Canada.

This speaker's sessions:

Back